期刊簡介 | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CLINICAL NEUROPHYSIOLOGY LetPub Score 6.5
50 ratings
Rate
Reputation 7.5 Influence 5.4 Speed 8.2 | ||||||||||||||||||||||||||||
期刊簡稱 | CLIN NEUROPHYSIOL | ||||||||||||||||||||||||||||
ISSN | 1388-2457 | ||||||||||||||||||||||||||||
E-ISSN | 1872-8952 | ||||||||||||||||||||||||||||
h-index | 164 | ||||||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||||||
自引率 (2023-2024) | 5.40%自引率趨勢 | ||||||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||||||
官方網站 | http://www.journals.elsevier.com/clinical-neurophysiology/ | ||||||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/CLINPH | ||||||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||||||
出版商 | Elsevier Ireland Ltd | ||||||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||||||
出版國/地區 | IRELAND | ||||||||||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||||||||||
創刊年 | 1999 | ||||||||||||||||||||||||||||
每年文章數 | 176每年文章數趨勢 | ||||||||||||||||||||||||||||
黃金OA百分比 | 38.99% | ||||||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1388-2457%5BISSN%5D | ||||||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Ordinary, 3-6 Week(s) 來自Elsevier的數據: Average 8.5 Week(s) | ||||||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 17.1 Week(s) | ||||||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[CLINICAL NEUROPHYSIOLOGY] 的評論 | 撰寫評論 |
作者: 碧波智志 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-16 16:51:41 評論於 Haha, feeling sorry for you researchers(0) 讚! | 碧波智志 |
作者: 长安学强 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-26 17:26:30 評論於 How long does it usually take to receive feedback from the first review?(0) 讚! | 长安学强 |
作者: 洗髓连明 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-06 09:03:12 評論於 Review speed: 6.0 | Submission hit rate: 25.0 Emphasized research direction: electrophysiology; Clinical experience sharing: Submitted on May 16th, received two review comments on October 2nd, and was eventually rejected. The first reviewer acknowledged the novelty of the article and had a more positive response. The second reviewer clearly did not understand the article, and even included a comment like "I have been in this field for 32 years, Thank God," which was something I had never seen before. Overall, I felt the comments from the associate editor were more important, as they suggested rejection in somewhat harsh terms, stating that I did not provide enough electrophysiology-related content and recommending submission to another journal. Although I have been worn down, I believe that if my content does not align with the journal's direction, it should have been rejected sooner(0) 讚! | 洗髓连明 |
作者: 法慧嘉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-08-21 19:13:43 評論於 Review speed: 2.0 Emphasis research direction: Neurology Brain EEG experience sharing: The revision took two months but there was no deadline given for the modifications. When asked by email, it was stated that there is no official deadline. What is the situation?(0) 讚! | 法慧嘉德 |
作者: Bartholomew Raphael 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-03-03 20:27:02 評論於 Review speed: 1.0 Sharing experience: Rejected within a week, claiming only a 30% acceptance rate and providing lots of feedback, while also checking for plagiarism(0) 讚! | Bartholomew Raphael |
作者: 璃沙耘豪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-10-10 12:50:48 評論於 How often is the cycle? lmfxub_92229226 posted on 2017-06-15 Research direction: Clinical Cognitive Neuroscience; Acceptance rate: about 25% Review time: about 2 months SCI (2016): 3.866 SCI (2015): 3.426 SCI (2014): 3.097 Just got one in. Major revision once. Minor revision once. Three reviewers. Two foreign reviewers thought the work was very good. One domestic reviewer insisted that I analyze the composition as he said. I stuck to my own method. Finally, the editor-in-chief approved my work. Not easy(0) 讚! | 璃沙耘豪 |
作者: 中原梓馨 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-06-15 22:12:31 評論於 Review Speed: 2.0 | Submission Success Rate: 25.0 Experience Sharing: Just had one accepted, with major revisions once and minor revisions once. Three reviewers, with two foreign experts saying the work was well done. One domestic reviewer insisted on a different method of analysis, but I stuck to my own approach. In the end, the editor-in-chief approved of my work. Not easy(0) 讚! | 中原梓馨 |
作者: 稻妻古韵 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-08-24 23:51:11 評論於 Review speed: 6.0 | Submission success rate: 50.0 Experience sharing: The editing and review process is quite fast, and the feedback from the reviewers is also quite objective(0) 讚! | 稻妻古韵 |
作者: Anonymous 領域: 医药科学 審稿時間: 6.0 month(s) 結果: 修改後接受 撰寫評論 |
2016-08-24 19:29:22 評論於 Review speed is fast and the comments made by the reviewers are very pertinent. (2) 讚! | Anonymous |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-07-01 16:24:46 評論於 It's too unpredictable, it dropped even more than last year. I wonder if we can maintain a 3-point margin next year, it all seems unreliable(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us